Trials / Completed
CompletedNCT03425513
Hepatitis B Virus Prevalence and Risk Factors in Belgium
Hepatitis B Virus Prevalence and Risk Factors in Middle Limburg Belgium: the Importance of Migration.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,131 (actual)
- Sponsor
- Hasselt University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study was to evaluate the current prevalence and risk factors of hepatitis B virus (HBV) infection in a multi-ethnic neighbourhood situated in Middle Limburg, Belgium. Additionally, the investigators will determine linkage of care in hepatitis B surface antigen (HBsAg) positive subjects.
Detailed description
Although the HBV prevalence is generally low in Western countries, such as Belgium, pockets of higher HBV prevalence exist in areas with large immigrant populations. Therefore national prevalence figures can underestimate the burden of HBV infection. The prevalence of chronic HBV in the population-based study in 2003 is believed to be an underestimate due to under-representation of the non-Belgian population. Moreover, by this time there are no data regarding the risk factors for HBV infection in the general population of Belgium. Even in low-prevalence areas such as Belgium, HBV prevention and control is a public health priority, particularly since safe and effective vaccines are available. The aim of this study was to evaluate the current prevalence and risk factors of HBV infection in a multi-ethnic neighbourhood situated in Middle Limburg, Belgium. Additionally, the investigators will determine linkage of care in hepatitis B surface antigen (HBsAg) positive subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Hepatitis B serology | A serum specimen will be taken and assessed for hepatitis B serology (HBsAg and anti-HBc antibodies). |
| OTHER | Questionnaire | Participants will be asked to fill in a questionnaire regarding demographic characteristics, known viral hepatitis status and risk factors for HBV infection. |
Timeline
- Start date
- 2017-05-12
- Primary completion
- 2017-11-27
- Completion
- 2017-11-27
- First posted
- 2018-02-07
- Last updated
- 2020-01-27
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03425513. Inclusion in this directory is not an endorsement.